<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">Ann Gastroenterol</journal-id><journal-title-group><journal-title>Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology</journal-title></journal-title-group><issn pub-type="ppub">1108-7471</issn><issn pub-type="epub">1792-7463</issn><publisher><publisher-name>Hellenic Society of Gastroenterology</publisher-name><publisher-loc>Greece</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27708522</article-id><article-id pub-id-type="pmc">5049563</article-id><article-id pub-id-type="publisher-id">AnnGastroenterol-29-530</article-id><article-id pub-id-type="doi">10.20524/aog.2016.0071</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Anesthesia for endoscopic retrograde cholangiopancreatography: target-controlled infusion versus standard volatile anesthesia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Motiaa</surname><given-names>Youssef</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Bensghir</surname><given-names>Mustapha</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Jaafari</surname><given-names>Abdelhamid</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Meziane</surname><given-names>Mohammed</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Ahtil</surname><given-names>Redouane</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Kamili</surname><given-names>Noureddine Drissi</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Anesthesiology and Critical Care, Mohamed V Military Hospital of Instruction, Faculty of Medicine and Pharmacy of Rabat, Mohamed V. University, Morocco</aff><author-notes><corresp id="cor1">
Correspondence to: Youssef Motiaa, MD, Department of Anesthesia and Critical Care, Mohammed V Military University Hospital, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco, Tel.: +212 0671195295, e-mail: <email xlink:href="youssefmotiaa@gmail.com">youssefmotiaa@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2016</year></pub-date><pub-date pub-type="epub"><day>14</day><month>7</month><year>2016</year></pub-date><volume>29</volume><issue>4</issue><fpage>530</fpage><lpage>535</lpage><history><date date-type="received"><day>27</day><month>3</month><year>2016</year></date><date date-type="accepted"><day>12</day><month>6</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Hellenic Society of Gastroenterology</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background</title><p>Endoscopic retrograde cholangiopancreatography (ERCP) is a technique used both for diagnosis and for the treatment of biliary and pancreatic diseases. ERCP has some anesthetic implications and specific complications. The primary outcome aim was to compare two protocols in terms of time of extubation. We also compared anesthetic protocols in terms of hemodynamic and respiratory instability, antispasmodics needs, endoscopist satisfaction, and recovery room stay.</p></sec><sec id="st2"><title>Methods</title><p>Patients were randomized into two groups standard anesthesia group (Gr: SA) in whom induction was done by propofol, fentanyl and cisatracurium and maintenance was done by a mixture of oxygen, nitrousoxide (50%:50%) and sevoflurane; and intravenous anesthesia group to target concentration (Gr: TCI) in whom induction and maintenance of anesthesia were done with propofol with a target 0.5-2 &#x003bc;g/mL, and remifentanil with a target of 0.75-2 ng/mL.</p></sec><sec id="st3"><title>Results</title><p>90 patients were included. Extubation time was shorter in Gr: TCI, 15&#x000b1;2.6 vs. 27.4&#x000b1;7.1 min in Gr: SA (P&#x0003c;0.001). The incidence of hypotension was higher in GrL: SA (P=0.009). Satisfaction was better in Gr: TCI (P=0.003). Antispasmodic need was higher in Gr: SA (P=0.023). Six patients in Gr: SA group had desaturation in post-anesthesia care unit (PACU) versus one patient from Gr: TCI (P=0.049). Patients in Gr: TCI had shorter PACU stay 40.2&#x000b1;7.3 vs. 58.7&#x000b1;12.4 min (P&#x0003c;0.001).</p></sec><sec id="st4"><title>Conclusion</title><p>The use of TCI mode allows better optimization of general anesthesia technique during ERCP.</p></sec></abstract><kwd-group><kwd>Endoscopic retrograde cholangiopancreatography</kwd><kwd>general anesthesia</kwd><kwd>anesthesia intravenous target concentration</kwd><kwd>complications</kwd><kwd>time of extubation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard in the diagnosis and treatment of biliary and pancreatic disease [<xref rid="ref1" ref-type="bibr">1</xref>]. In France, about 45,000 patients underwent this technique [<xref rid="ref2" ref-type="bibr">2</xref>]. The use of this technique has a diagnostic and therapeutic interest, as it is indicated for patients with co-morbidities [<xref rid="ref3" ref-type="bibr">3</xref>]. In fact, with the wide use of ERCP, many critical patients in whom conventional surgery was a high-risk procedure could be managed by endoscopic treatment.</p><p>Because of patient&#x02019;s status and procedures difficulties, the choice of the anesthetic technique presents a real challenge. Many techniques have been proposed [<xref rid="ref4" ref-type="bibr">4</xref>-<xref rid="ref9" ref-type="bibr">9</xref>] with sedation used mostly [<xref rid="ref7" ref-type="bibr">7</xref>-<xref rid="ref9" ref-type="bibr">9</xref>]. However, it carries some risks [<xref rid="ref10" ref-type="bibr">10</xref>-<xref rid="ref14" ref-type="bibr">14</xref>], and the use of general anesthesia may be necessary in some patients. Because of co-morbidities in patients undergoing ERCP, the optimization of general anesthesia for this technique is necessary. We thus conducted a prospective study to compare two anesthetic protocols: general anesthesia versus intravenous anesthesia target controlled.</p></sec><sec sec-type="methods" id="sec1-2"><title>Patients and methods</title><p>The study protocol was approved by the local ethics committee of the Mohammed V Military Hospital at Rabat. All patients scheduled for elective ERCP between January and June 2011 were recruited in the study and provided written informed consent. Exclusion criteria were: allergy to iodinated contrast agents; propofol or morphine; age less than 18 years; chronic use of morphine; pregnancy; full stomach; difficult intubation criteria; and patients undergoing emergency ERCP and who required surgical conversion for intra-operative complication. All ERCPs were conducted by the same team of anesthesiologists and endoscopists.</p><p>For each included patient, demographic factors [age, sex, body mass index (BMI)], ASA classification, diagnosis, and endoscopic intervention were noted. Patients included were randomized into two groups according to anesthetic protocol: standard anesthesia (Gr: SA), and target-controlled infusion (Gr: TCI) using sealed envelopes.</p></sec><sec id="sec1-3"><title>Anesthetic protocol</title><p>In the pre-anesthetic consultation, all chronic treatments were managed as recommended. After a fasting period of 6 h and premedication with hydroxyzine (1 mg/kg) the night before and the morning of procedure, patients were taken to the operating room. The anesthesiologist opened the sealed envelope and prepared the anesthetic technique as indicated. All patients were continuously monitored for heart rate (by using a three-lead electrocardiogram), blood pressure (by using an automated blood pressure cuff and serial measurements every 5 min), oxygen saturation (by pulse oximetry) and capnography. Vascular access was secured in all patients via peripheral vein and infusion of 0.9% saline (5 mL/kg) was started. In addition, a dose of 2 g of amoxicillin and clavulanic acid was administered prior to the procedure.</p><p>After 3 min of pre-oxygenation and expired oxygen fraction superior to 92%, anesthesia was induced in both groups:</p><p>
<list list-type="bullet"><list-item><p>Gr: SA: induction was done by fentanyl (1-2 &#x000b5;g/kg) and propofol (1.5-2 mg/kg) and maintenance was performed by sevoflurane (1-1.5%) and 50% mix of N<sub>2</sub>O and oxygen.</p></list-item><list-item><p>Gr: TCI: induction and maintenance were done with propofol and remifentanil. For induction, propofol (10 mg/mL) was started with the Schnider model with an initial target of 0.5 ng/mL. For remifentanil (50 &#x003bc;g/mL), it was administered by the Minto model with an initial target of 0.75 ng/mL. Maintenance of anesthesia was done by the same drugs in TCI mode.</p></list-item></list>
</p><p>In all patients, Muscle relaxation was achieved with cisatracurium (0.15 mg/kg). Variation less than 30% of the mean arterial pressure (MAP) and heart rate (HR) was considered as hemodynamic objectives.</p><sec id="sec2-1"><title>Study design</title><p>The primary endpoint of the study was extubation timing between Gr: SA and Gr: TCI. Peri-operative hemodynamic and respiratory complications, needs of antispasmodic, overall satisfaction by endoscopist, and stay in the recovery room were compared.</p><p>MAP and HR were recorded just before and during induction, and continually every 5 min. In cases of hypotension, measurements were made every minute until stabilization of MAP. Oxygen saturation was continually monitored throughout the procedure. At the end of the intervention, target concentrations were set to zero in the Gr: TCI, sevoflurane and nitrous oxide were arrested in the Gr: SA with increasing fresh gas flow to 10 L/min. The extubation timing was defined as the time between the end of the intervention and the patient extubation according to the recommended criteria. The hemodynamic variations of HR and MAP were defined by any variation over 30% compared to reference values. Hypotension was treated by solution infusion and administration of vasoconstrictors (ephedrine: bolus of 3 mg/mL). Hypertension was treated by increasing the sedation depth with propofol bolus (20 mg) and/or fentanyl (25 &#x003bc;g) in the (Gr: SA) and by increasing the target propofol (0.1 &#x003bc;g) and remifentanil (0.1 ng) in the (Gr: TCI). Desaturation was defined as SpO<sub>2</sub> less than 95%. HR, MAP and SpO<sub>2</sub> values before induction were taken as reference values.</p><p>The intravenous administration of antispasmodic: phloroglucinol (80 mg) was made at the endoscopist request. The satisfaction of the endoscopy team was judged on three classes: low, medium and high satisfaction. Thirty minutes before the end of procedure, analgesia was provided by paracetamol (1 g) and intravenous infusion of nefopam (20 mg).</p><p>All patients were extubated in the operating room, and were admitted to the post-anesthesia care unit (PACU), where they were monitored (electrocardiogram, SpO<sub>2</sub>, noninvasive blood pressure) and they received intranasal supplemental oxygen (2 L/min). Patients left PACU when their vital signs were within normal range.</p></sec><sec id="sec2-2"><title>Statistical analysis</title><p>In a pilot study (performed in our institution) a difference of 10&#x000b1;5 min was noted between the two groups. Based on this study, we considered that a reduction by 33% in extubation time was important to show the difference [with an error (&#x003b1;) of 5% and power (&#x003b2;) of 80%], the number of patients to include was estimated at 36 per group. To increase the power of the study and reduce excluded patients during the study, we decided to include 45 patients per group. Statistical analysis was made by SPSS for Windows, version 13 (SPSS, Inc, Chicago, IL, USA). The chi-square test or Fisher&#x02019;s exact test were used to compare categorical data when appropriate. Student&#x02019;s <italic>t</italic>-test was used for continuous data. A P value &#x0003c;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec1-4"><title>Results</title><p>Between January 2011 and June 2011, 110 patients eligible for inclusion were selected. 20 patients were excluded and 90 were included with 45 in each group (<xref ref-type="fig" rid="F1">Fig. 1</xref>: flow diagram). No significant differences were noted between the two groups regarding age, sex, BMI, ASA classification or diagnosis (<xref ref-type="table" rid="T1">Table 1</xref>). Extubation time was shorter in Gr: TCI with a mean time of 15&#x000b1;2.6 than 27.4&#x000b1;7.1 min in Gr: SA (P&#x0003c;0.001). The incidence of hypotension was higher in Gr: SA than Gr: TCI (P=0.009). Endoscopist&#x02019;s satisfaction was better in Gr: TCI than Gr: SA (P=0.003). In Gr: TCI, intraoperative targets ranged between 0.5 and 2 ng/mL for propofol and between 0.75 and 2 ng/mL for remifentanil. Need for antispasmodics was higher in Gr: SA than Gr: TCI (P=0.023). Six patients presented desaturation in the recovery room in Gr: SA vs a single patient in the Gr: TCI (P=0.049). The length of the stay in the recovery room was shorter in Gr: TCI than in Gr: SA, with durations of 58.7&#x000b1;12.4 and 40.2min &#x000b1; 7.3 min respectively (P&#x0003c;0.001). One ICU admission for heart failure was needed in the Gr: SA (<xref ref-type="table" rid="T2">Table 2</xref>); follow up was favorable and the patient was discharged at day two postoperatively.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Flow diagram of the process of study evaluation</p></caption><graphic xlink:href="AnnGastroenterol-29-530-g001"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Population characteristics and endoscopic retrograde cholangiopancreatography indications</p></caption><graphic xlink:href="AnnGastroenterol-29-530-g002"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Intraprocedure and recovery room event data</p></caption><graphic xlink:href="AnnGastroenterol-29-530-g003"/></table-wrap></sec><sec sec-type="discussion" id="sec1-5"><title>Discussion</title><p>During ERCP, the use of TCI mode allows better optimization of the general anesthesia, with a shorter extubation time, decreased demand for antispasmodics and less peri-operative complications compared to standard anesthetic technique.</p><p>ERCP is the gold standard in the diagnosis and treatment of biliary and pancreatic disease [<xref rid="ref1" ref-type="bibr">1</xref>]. This technique is often directed to a fragile population and the spectrum of therapeutic applications of ERCP continues to expand, enabling treatment of more complex biliopancreatic disease. The requirement for open surgical and percutaneous techniques has diminished and almost all biliary diseases are now amenable to endoscopic treatment. As a result, many patients previously considered to be inoperable or with life-threatening conditions can now undergo therapeutic ERCP. Martindale <italic>et al</italic> reported that 46% of patients who presented for ERCP are ASA physical status 3-5. In such patients, this technique is the optimal treatment of bile duct stones with a success rate of 98%, and improves their quality of life with few associated postoperative complications for neoplastic disease of the bile duct [<xref rid="ref3" ref-type="bibr">3</xref>].</p><p>Anesthesia and analgesia are important elements for the realization of interventional endoscopic procedures. They reduce pain, discomfort and stress for patients and contribute to improved tolerance, patient comfort and success of procedure with the least morbidity [<xref rid="ref5" ref-type="bibr">5</xref>]. Many anesthetic techniques are used, ranging from sedation to general anesthesia. The worldwide accepted method is deep sedation in the presence of an anesthetist without intubation. Intubation is recommended in very exceptional cases.</p><p>Sedation is the most practiced anesthetic technique in most published series [<xref rid="ref6" ref-type="bibr">6</xref>]. Propofol is the most used drug in this indication [<xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref15" ref-type="bibr">15</xref>]. It reduces procedure time and improves the level of comfort and intra-operative amnesia [<xref rid="ref5" ref-type="bibr">5</xref>]. Several methods of administration of the product have been evaluated. Intermittent bolus injection remains the most practiced method [<xref rid="ref16" ref-type="bibr">16</xref>], in addition to sedation controlled by the patient [<xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref17" ref-type="bibr">17</xref>] and the target controlled infusion [<xref rid="ref18" ref-type="bibr">18</xref>-<xref rid="ref20" ref-type="bibr">20</xref>].</p><p>ERCP is an uncomfortable procedure requiring adequate sedation or general anesthesia. The required level of sedation during these procedures is often deep. The patient cooperation is an imperative factor for the success of the procedure especially, to avoid intra-operative complications such as duodenal perforations. This deep sedation may compromise the safety of the upper airways and be a source of complications, especially respiratory. Desaturation remains the most observed adverse event [<xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref15" ref-type="bibr">15</xref>,<xref rid="ref21" ref-type="bibr">21</xref>,<xref rid="ref22" ref-type="bibr">22</xref>].</p><p>During sedation for ERCP, several factors may cause desaturation such as advanced age, associated cardiopulmonary co-morbidity, depth of sedation, procedure duration, and the patient&#x02019;s position [<xref rid="ref12" ref-type="bibr">12</xref>]. This desaturation may be secondary to respiratory depression or inhalation. It is the leading cause of perioperative mortality from cardiovascular complications by causing arrhythmias, myocardial infarction and cardiac arrest, especially in patients with a history of heart disease [<xref rid="ref14" ref-type="bibr">14</xref>].</p><p>The short duration of some interventions, the low incidence of complications, and intubation requirement, associated with the low cost of the procedure are strong arguments for supporters of sedation. The optimization of sedation technique involves choosing an adequate monitoring including oxygenation, depth of anesthesia and especially capnography [<xref rid="ref23" ref-type="bibr">23</xref>,<xref rid="ref24" ref-type="bibr">24</xref>].</p><p>According to some authors, general anesthesia is less used as an anesthetic technique in ERCP [<xref rid="ref12" ref-type="bibr">12</xref>]: its major limitation remain the short duration of ERCP, the risk of residual neuromuscular blockade and the high cost. Respiratory and cardiovascular complications are commonly observed with sedation compared to general anesthesia. In a retrospective analysis of 650 procedures, in which 367 were done under sedation, and 238 under general anesthesia, the sedation group patients had significantly more respiratory complications than the general anesthesia group with 13 cases of desaturation requiring mask ventilation in two patients and tracheal intubation in two other patients. In the general anesthesia group, only one patient required a prolongation of mechanical ventilation [<xref rid="ref12" ref-type="bibr">12</xref>]. In our study, we opted for tracheal intubation in all patients because of the use of muscle relaxants and the need to change patient position. The use of the gastro-laryngeal tube, reported in small series is not without risk as patients may suffer from inhalation, dysphonia and dysphagia [<xref rid="ref25" ref-type="bibr">25</xref>,<xref rid="ref26" ref-type="bibr">26</xref>].</p><p>To reduce the procedure duration, some authors opt for handiest drugs and using a target-controlled anesthesia mode that allows a shortening of the duration of anesthesia [<xref rid="ref19" ref-type="bibr">19</xref>,<xref rid="ref20" ref-type="bibr">20</xref>]. TCI is a technique based on the intravenous anesthetic drug infusion device controlled by a software integrated in the device, the infusion rate calculations are based on pharmacokinetic modeling previously validated [<xref rid="ref27" ref-type="bibr">27</xref>,<xref rid="ref28" ref-type="bibr">28</xref>]. The adjustment of the dose of anesthetic drugs administered is done according to desired concentrations in the brain or the plasma. Propofol, remifentanil and sufentanil are still the most used drugs by this administration mode [<xref rid="ref28" ref-type="bibr">28</xref>,<xref rid="ref29" ref-type="bibr">29</xref>]. This technique is increasingly used by different centers. However, some authors concluded that further efforts are still needed regarding the availability of devices, knowledge and control of this technique by anesthesiologists [<xref rid="ref30" ref-type="bibr">30</xref>].</p><p>TCI, compared to bolus administration technique or continuous infusion, provides a stable anesthesia level. This drug&#x02019;s titration offers a better control of anesthesia, the maintaining of spontaneous ventilation, hemodynamic stability and a better recovery [<xref rid="ref20" ref-type="bibr">20</xref>]. Therefore, sedation in spontaneous ventilation and anesthesia in elderly and fragile patients represents the main indications of TCI [<xref rid="ref28" ref-type="bibr">28</xref>]. In fact, when comparing a standard anesthesia protocol with continuous infusion of propofol and remifentanil to an anesthesia procedure with propofol in TCI mode and continuous infusion remifentanil in a series of 338 patients, undergoing coronary surgery, the authors showed that the tracheal extubation was earlier in the TCI group, but patients in this group required more transfusion and vaso-active drugs [<xref rid="ref31" ref-type="bibr">31</xref>]. In another prospective study that compares two modes of administration (manual and TCI) of propofol and alfentanil, the authors randomized 220 patients undergoing sedation for gastrointestinal endoscopy. In this study, the recovery time is shorter in the TCI group with less hypotensive episodes and bradypnea. In addition, the risk of desaturation is reduced by 50% in TCI group [<xref rid="ref32" ref-type="bibr">32</xref>]. In our study, the recovery time was shorter in patients receiving intravenous anesthesia with target concentrations compared to patients undergoing standard anesthesia. The reduced use of antispasmodics in the TCI group could be explained by the small effect of remifentanil on the sphincter of Oddi. Compared to morphine, meperidine and remifentanil, it causes less contraction of the Oddi&#x02019;s sphincter [<xref rid="ref33" ref-type="bibr">33</xref>].</p><p>TCI limitation is explained by the fact that it is based on the predicted and not the real concentrations in the plasma or brain [<xref rid="ref29" ref-type="bibr">29</xref>]. To overcome this limitation, the use of monitoring of the anesthesia depth by the bi-spectral index (BIS) for propofol could optimize these concentrations to the specific needs of each patient [<xref rid="ref34" ref-type="bibr">34</xref>,<xref rid="ref36" ref-type="bibr">36</xref>]. Some authors reported that closed-loop administration of propofol with TCI, using BIS optimizes this technique [<xref rid="ref37" ref-type="bibr">37</xref>,<xref rid="ref38" ref-type="bibr">38</xref>].</p><p>ERCP is for a high anesthetic risk population; all efforts must be used to reduce the peri-operative risk. Others factors may influence this risk such as: the experience of the anesthetic team, the anesthesiologists or nurses practicing the anesthesia and the operating room [<xref rid="ref39" ref-type="bibr">39</xref>]. In a retrospective study, analyzing 1167 sedated patients for ERCP, the authors showed that the experience of the anesthetic team is associated with a lower incidence of desaturation, use of endotracheal intubation and a lower cost of the procedure [<xref rid="ref40" ref-type="bibr">40</xref>]. Patients were transferred to the gastroenterology or surgery department for their postoperative stay. Postoperative morbidity was not analyzed in this study.</p><p>In conclusion, the use of TCI mode allows a better optimization of general anesthesia with short extubation time, decreased need for antispasmodics and less peri-operative complications compared to standard anesthetic technique.</p><boxed-text position="float"><caption><title>Summary Box</title></caption><p><bold>What is already known:</bold></p><p>
<list list-type="bullet"><list-item><p>Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard in the diagnosis and treatment of biliary and pancreatic disease</p></list-item><list-item><p>Deep sedation without intubation is the most practice anesthetic technique and intubation is recommended in very exceptional cases</p></list-item><list-item><p>Propofol is the most used drug for sedation</p></list-item></list>
</p><p><bold>What the new findings are:</bold></p><p>
<list list-type="bullet"><list-item><p>For patients undergoing an ERCP requiring general anesthesia with intubation, target-controlled infusion allows shorter extubation time, more respiratory and hemodynamic stability, and better satisfaction of the endoscopic team than standard anesthesia</p></list-item></list>
</p></boxed-text></sec></body><back><fn-group><fn fn-type="COI-statement"><p>Conflict of Interest: None</p></fn></fn-group><bio id="d36e73"><p>Mohamed V Military Hospital of Instruction, Mohamed V University, Morocco</p></bio><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>SK</given-names></name><name><surname>Mutignani</surname><given-names>M</given-names></name><name><surname>Costamagna</surname><given-names>G</given-names></name></person-group><article-title>Therapeutic biliary endoscopy</article-title><source>Endoscopy</source><year>2002</year><volume>34</volume><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">11778129</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Servin</surname><given-names>F</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Sfar</surname></name></person-group><article-title>Anesth&#x000e9;sie pour endoscopie digestive</article-title><source>Conf&#x000e9;rence d&#x02019;actualisation. 53e Congr&#x000e8;s national d&#x02019;anesth&#x000e9;sie et de r&#x000e9;animation</source><year>2011</year><publisher-loc>Paris</publisher-loc><publisher-name>Elsevier</publisher-name></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>JH</given-names></name><name><surname>Kasmin</surname><given-names>FE</given-names></name></person-group><article-title>Biliary tract diseases in the elderly: management and outcomes</article-title><source>Gut</source><year>1997</year><volume>41</volume><fpage>433</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">9391238</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martindale</surname><given-names>SJ</given-names></name></person-group><article-title>Anaesthetic considerations during endoscopic retrograde cholangiopancreatography</article-title><source>Anaesth Intensive Care</source><year>2006</year><volume>34</volume><fpage>475</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">16913345</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapoor</surname><given-names>H</given-names></name></person-group><article-title>Anaesthesia for endoscopic retrograde cholangiopancreatography</article-title><source>Acta Anaesthesiol Scand</source><year>2011</year><volume>55</volume><fpage>918</fpage><lpage>926</lpage><pub-id pub-id-type="pmid">21658012</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garewal</surname><given-names>D</given-names></name><name><surname>Vele</surname><given-names>L</given-names></name><name><surname>Waikar</surname><given-names>P</given-names></name></person-group><article-title>Anaesthetic considerations for endoscopic retrograde cholangio-pancreatography procedures</article-title><source>Curr Opin Anaesthesiol</source><year>2013</year><volume>26</volume><fpage>475</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">23635608</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazanikov</surname><given-names>M</given-names></name><name><surname>Udd</surname><given-names>M</given-names></name><name><surname>Kyl&#x000e4;np&#x000e4;&#x000e4;</surname><given-names>L</given-names></name><etal/></person-group><article-title>Patient-controlled sedation with propofol and remifentanil for ERCP: a randomized, controlledstudy</article-title><source>Gastrointest Endosc</source><year>2011</year><volume>73</volume><fpage>260</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">21295639</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froehlich</surname><given-names>F</given-names></name><name><surname>Schwizer</surname><given-names>W</given-names></name><name><surname>Thorens</surname><given-names>J</given-names></name><name><surname>K&#x000f6;hler</surname><given-names>M</given-names></name><name><surname>Gonvers</surname><given-names>JJ</given-names></name><name><surname>Fried</surname><given-names>M</given-names></name></person-group><article-title>Conscious sedation for gastroscopy: patient tolerance and cardiorespiratory parameters</article-title><source>Gastroenterology</source><year>1995</year><volume>108</volume><fpage>697</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">7875472</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chainaki</surname><given-names>IG</given-names></name><name><surname>Manolaraki</surname><given-names>MM</given-names></name><name><surname>Paspatis</surname><given-names>GA</given-names></name></person-group><article-title>Deep sedation for ERCP</article-title><source>World J Gastrointest Endosc</source><year>2011</year><volume>3</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">21403815</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>ML</given-names></name></person-group><article-title>Adverse outcomes of ERCP</article-title><source>Gastrointest Endosc</source><year>2002</year><volume>56</volume><issue>6 Suppl</issue><fpage>S273</fpage><lpage>S282</lpage><pub-id pub-id-type="pmid">12447281</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Baillie</surname><given-names>J</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Jacobson</surname><given-names>I</given-names></name></person-group><article-title>Complications of ERCP</article-title><source>ERCP and its applications</source><year>1998</year><edition>1st ed</edition><publisher-loc>Philadelphia-New York</publisher-loc><publisher-name>Lippincot-Raven Publishers</publisher-name><fpage>37</fpage><lpage>54</lpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorser</surname><given-names>SA</given-names></name><name><surname>Fan</surname><given-names>DS</given-names></name><name><surname>Tommolino</surname><given-names>EE</given-names></name><etal/></person-group><article-title>Complications of ERCP in patients undergoing general anesthesia versus MAC</article-title><source>Dig Dis Sci</source><year>2014</year><volume>59</volume><fpage>696</fpage><lpage>697</lpage><pub-id pub-id-type="pmid">24202650</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raksakietisak</surname><given-names>M</given-names></name></person-group><article-title>Unrecognised aspiration pneumonitis during enteroscopy: two cases report</article-title><source>J Med Assoc Thai</source><year>2009</year><volume>92</volume><fpage>869</fpage><lpage>871</lpage><pub-id pub-id-type="pmid">19530596</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berzin</surname><given-names>TM</given-names></name><name><surname>Sanaka</surname><given-names>S</given-names></name><name><surname>Barnett</surname><given-names>SR</given-names></name><etal/></person-group><article-title>A prospective assessment of sedation-related adverse events and patient and endoscopist satisfaction in ERCP with anesthesiologist-administered sedation</article-title><source>Gastrointest Endosc</source><year>2011</year><volume>73</volume><fpage>710</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">21316669</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WX</given-names></name><name><surname>Lin</surname><given-names>HJ</given-names></name><name><surname>Zhang</surname><given-names>WF</given-names></name><etal/></person-group><article-title>Sedation and safety of propofol for therapeutic endoscopic retrograde cholangiopancreatography</article-title><source>Hepatobiliary Pancreat Dis Int</source><year>2005</year><volume>4</volume><fpage>437</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">16109532</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riphaus</surname><given-names>A</given-names></name><name><surname>Wehrmann</surname><given-names>T</given-names></name><name><surname>Weber</surname><given-names>B</given-names></name><etal/></person-group><article-title>S3-guidelines-sedation in gastrointestinal endoscopy</article-title><source>Z Gastroenterol</source><year>2008</year><volume>46</volume><fpage>1298</fpage><lpage>1330</lpage><pub-id pub-id-type="pmid">19012203</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jowell</surname><given-names>PS</given-names></name><name><surname>Eisen</surname><given-names>G</given-names></name><name><surname>Onken</surname><given-names>J</given-names></name><name><surname>Bute</surname><given-names>BP</given-names></name><name><surname>Ginsberg</surname><given-names>B</given-names></name></person-group><article-title>Patient-controlled analgesia for conscious sedation during endoscopic retrograde cholangiopancreatography: a randomized controlled trial</article-title><source>Gastrointest Endosc</source><year>1996</year><volume>43</volume><fpage>490</fpage><lpage>494</lpage><pub-id pub-id-type="pmid">8726764</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazanikov</surname><given-names>M</given-names></name><name><surname>Udd</surname><given-names>M</given-names></name><name><surname>Kyl&#x000e4;np&#x000e4;&#x000e4;</surname><given-names>L</given-names></name><etal/></person-group><article-title>A randomized comparaison of target-controlled propofol infusion and patient-controlled sedation during ERCP</article-title><source>Endoscopy</source><year>2013</year><volume>45</volume><fpage>915</fpage><lpage>919</lpage><pub-id pub-id-type="pmid">24104763</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillham</surname><given-names>MJ</given-names></name><name><surname>Hutchinson</surname><given-names>RC</given-names></name><name><surname>Carter</surname><given-names>R</given-names></name><name><surname>Kenny</surname><given-names>GN</given-names></name></person-group><article-title>Patient-maintained sedation for ERCP with a target controlled infusion of propofol: a pilot study</article-title><source>Gastrointest Endosc</source><year>2001</year><volume>54</volume><fpage>14</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">11427835</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanti</surname><given-names>L</given-names></name><name><surname>Agostoni</surname><given-names>M</given-names></name><name><surname>Casati</surname><given-names>A</given-names></name><etal/></person-group><article-title>Target-Controlled propofol infusion during monitored anesthesia in patients undergoing ERCP</article-title><source>Gastrointest Endosc</source><year>2004</year><volume>60</volume><fpage>361</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">15332024</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kongkam</surname><given-names>P</given-names></name><name><surname>Rerknimitr</surname><given-names>R</given-names></name><name><surname>Punyathavorn</surname><given-names>S</given-names></name><etal/></person-group><article-title>Propofol infusion versus intermittent meperidine and midazolam injection for conscious sedation in ERCP</article-title><source>J J Gastrointestin Liver Dis</source><year>2008</year><volume>17</volume><fpage>291</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">18836622</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goudra</surname><given-names>B</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Sinha</surname><given-names>A</given-names></name></person-group><article-title>Outpatient endoscopic retrograde cholangiopancreatography: safety and efficacy of anesthetic management with a natural airway in 653 consecutive procedures</article-title><source>Saudi J Anaesth</source><year>2013</year><volume>7</volume><fpage>259</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">24015127</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>DR</given-names></name><name><surname>Jagannath</surname><given-names>S</given-names></name><name><surname>Baron</surname><given-names>TH</given-names></name><etal/></person-group><article-title>Sedation and anesthesia in GI endoscopy. Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy</article-title><source>Gastrointest Endosc</source><year>2008</year><volume>68</volume><fpage>815</fpage><lpage>826</lpage><pub-id pub-id-type="pmid">18984096</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>J</given-names></name></person-group><article-title>The latest ASA mandate: CO(2) monitoring for moderate and deep sedation</article-title><source>Anesth Prog</source><year>2011</year><volume>58</volume><fpage>111</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">21882985</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabbri</surname><given-names>C</given-names></name><name><surname>Luigiano</surname><given-names>C</given-names></name><name><surname>Cennamo</surname><given-names>V</given-names></name><etal/></person-group><article-title>The Gastro-Laryngeal Tube for interventional endoscopic biliopancreatic procedures in anesthetized patients</article-title><source>Endoscopy</source><year>2012</year><volume>44</volume><fpage>1051</fpage><lpage>1054</lpage><pub-id pub-id-type="pmid">22983834</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaitini</surname><given-names>LA</given-names></name><name><surname>Lavi</surname><given-names>A</given-names></name><name><surname>Stermer</surname><given-names>E</given-names></name><name><surname>Charco Mora</surname><given-names>P</given-names></name><name><surname>Pott</surname><given-names>LM</given-names></name><name><surname>Vaida</surname><given-names>SJ</given-names></name></person-group><article-title>Gastro-laryngeal tube for endoscopic retrograde cholangiopancreatography: a preliminary report</article-title><source>Anaesthesia</source><year>2010</year><volume>65</volume><fpage>1114</fpage><lpage>1118</lpage><pub-id pub-id-type="pmid">20860646</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billard</surname><given-names>V</given-names></name><name><surname>Cazala&#x000e0;</surname><given-names>JB</given-names></name><name><surname>Servin</surname><given-names>F</given-names></name><name><surname>Viviand</surname><given-names>X</given-names></name></person-group><article-title>Target-controlled intravenous anesthesia. [Article in French]</article-title><source>Ann Fr Anesth Reanim</source><year>1997</year><volume>16</volume><fpage>250</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">9732774</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billard</surname><given-names>V</given-names></name></person-group><article-title>Target controlled infusion of opioid in clinical practice. [Article in French]</article-title><source>Le Praticien en anesth&#x000e9;sie r&#x000e9;animation</source><year>2009</year><volume>13</volume><fpage>34</fpage><lpage>40</lpage></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Billard</surname><given-names>V</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Sfar</surname></name></person-group><article-title>Anesth&#x000e9;sie &#x000e0;objectif de concentration intraveineuse (AIVOC) et inhal&#x000e9;e (AINOC)</article-title><source>Conf&#x000e9;rences d&#x02019;actualisation. 56e Congr&#x000e8;s national d&#x02019;anesth&#x000e9;sie et de r&#x000e9;animation</source><year>2014</year><publisher-loc>Paris</publisher-loc><publisher-name>Elsevier</publisher-name></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertarrex</surname><given-names>A</given-names></name><name><surname>Billard</surname><given-names>V</given-names></name><name><surname>Molliex</surname><given-names>S</given-names></name><name><surname>Passot</surname><given-names>S</given-names></name><name><surname>Sztark</surname><given-names>F</given-names></name></person-group><article-title>Anesth&#x000e9;sie intraveineuse &#x000e0;objectif de concentration (AIVOC): enqu&#x000ea;te nationale 2013</article-title><source>Ann Fr Anesth R&#x000e9;anim</source><year>2014</year><volume>33</volume><issue>Suppl. 2</issue><fpage>A142</fpage><lpage>A143</lpage></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardellin</surname><given-names>M</given-names></name><name><surname>Durand</surname><given-names>M</given-names></name><name><surname>Maitrasse</surname><given-names>B</given-names></name><etal/></person-group><article-title>Continuous infusion of remifentanil and target-controlled infusion of propofol for coronarysurgery in elderly patients: Comparaison with continous infusion of remifentanil and propofol. [Article in French]</article-title><source>Ann Fr Anesth Reanim</source><year>2004</year><volume>23</volume><fpage>966</fpage><lpage>972</lpage><pub-id pub-id-type="pmid">15501626</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>MH</given-names></name><name><surname>Wu</surname><given-names>SC</given-names></name><name><surname>You</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Target-controlled infusion vs. manually controlled infusion of propofol with alfentanil for bidirectional endoscopy: a randomized controlled trial</article-title><source>Endoscopy</source><year>2013</year><volume>45</volume><fpage>907</fpage><lpage>914</lpage><pub-id pub-id-type="pmid">24165817</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fragen</surname><given-names>RJ1</given-names></name><name><surname>Vilich</surname><given-names>F</given-names></name><name><surname>Spies</surname><given-names>SM</given-names></name><name><surname>Erwin</surname><given-names>WD</given-names></name></person-group><article-title>The effect of remifentanil on biliary tract drainage into the duodenum</article-title><source>Anesth Analg</source><year>1999</year><volume>89</volume><fpage>1561</fpage><lpage>1564</lpage><pub-id pub-id-type="pmid">10589649</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahli</surname><given-names>A</given-names></name><name><surname>Coskun</surname><given-names>D</given-names></name><name><surname>Karaca</surname><given-names>GI</given-names></name><name><surname>Akcali</surname><given-names>DT</given-names></name><name><surname>Karabiyik</surname><given-names>L</given-names></name><name><surname>Karadenizli</surname><given-names>Y</given-names></name></person-group><article-title>Target-controlled infusion of remifentanil with propofol or desflurane under bispectral index guidance: quality of anesthesia and recovery profile</article-title><source>J Res Med Sci</source><year>2011</year><volume>16</volume><fpage>611</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">22091283</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paspatis</surname><given-names>GA</given-names></name><name><surname>Chainaki</surname><given-names>I</given-names></name><name><surname>Manolaraki</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Efficacy of bispectral index monitoring as an adjunct to propofol deep sedation for ERCP: a randomized controlled trial</article-title><source>Endoscopy</source><year>2009</year><volume>41</volume><fpage>1046</fpage><lpage>1051</lpage><pub-id pub-id-type="pmid">19967620</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruenewald</surname><given-names>M</given-names></name><name><surname>Ilies</surname><given-names>C</given-names></name><name><surname>Herz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Influence of nociceptive stimulation on analgesia nociception index (ANI) during propofol-remifentanil anaesthesia</article-title><source>Br J Anaesth</source><year>2013</year><volume>110</volume><fpage>1024</fpage><lpage>1030</lpage><pub-id pub-id-type="pmid">23471754</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Chazot</surname><given-names>T</given-names></name><name><surname>Hamada</surname><given-names>S</given-names></name><etal/></person-group><article-title>Closed-loop administration of propofol and remifentanil guided by bispectral index: a randomized multicenter study</article-title><source>Anesth Analg</source><year>2011</year><volume>112</volume><fpage>546</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">21233500</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Le</surname><given-names>Guen M</given-names></name><name><surname>Benabbes-Lambert</surname><given-names>F</given-names></name><etal/></person-group><article-title>Feasibility of closed-loop titration of propofol and remifentanil guided by the spectral M-Entropy monitor</article-title><source>Anesthesiology</source><year>2012</year><volume>116</volume><fpage>286</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">22222478</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumonceau</surname><given-names>JM</given-names></name><name><surname>Riphaus</surname><given-names>A</given-names></name><name><surname>Aparicio</surname><given-names>JR</given-names></name><etal/></person-group><article-title>European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guidelines: Non-anesthesiologist administration of propofol of GI endoscopy</article-title><source>Endoscopy</source><year>2010</year><volume>42</volume><fpage>960</fpage><lpage>974</lpage><pub-id pub-id-type="pmid">21072716</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goudra</surname><given-names>BG</given-names></name><name><surname>Singh</surname><given-names>PM</given-names></name><name><surname>Sinha</surname><given-names>AC</given-names></name></person-group><article-title>Anesthesia for ERCP: impact of anesthesiologist&#x02019;s experience on outcome and cost</article-title><source>Anesthesiol Res Pract</source><year>2013</year><volume>2013</volume><fpage>570518</fpage><pub-id pub-id-type="pmid">23781243</pub-id></element-citation></ref></ref-list></back></article>